Odessa Addison1, Alice S Ryan, Steven J Prior, Leslie I Katzel, Rishi Kundi, Brajesh K Lal, Andrew W Gardner. 1. 1Department of Medicine, Division of Gerontology, University of Maryland, Baltimore. 2Department of Veterans Affairs and Veterans Affairs Medical Center, Geriatric Research, Education and Clinical Centers, Baltimore, Maryland. 3Department of Surgery, Division of Vascular Surgery, University of Maryland, Baltimore. 4Reynolds Oklahoma Center on Aging, Donald W. Reynolds Department of Geriatric Medicine, University of Oklahoma Health Sciences Center, Oklahoma City.
Abstract
BACKGROUND AND PURPOSE: Both obesity and peripheral artery disease (PAD) limit function and may work additively to reduce mobility. The purpose of this study was to compare the effects of a 6-month, center-based walking program on mobility function between adults who are weight-stable obese and nonobese with PAD. METHODS: This is a secondary data analysis of 2 combined studies taken from previous work. Fifty-three adults with PAD and intermittent claudication participated in 6 months oftreadmill training or standard of care. Patients were divided into 4 groups for analyses: exercise nonobese (Ex), exercise obese (ExO), standard-of-care nonobese (SC), and standard-of-care obese (SCO). Mobility was assessed by a standardized treadmill test to measure claudication onset time (COT) and peak walking time (PWT) as well as the distance walked during a 6-minute walk distance (6MWD) test. RESULTS: There was a significant (P < .001) interaction (intervention × obesity) effect on 6MWD, wherein both exercise groups improved (Ex = 7%, ExO = 16%; P < .02), the SC group did not change (0.9%; P > .05), and the SCO group tended to decline (-18%; P = .06). Both exercise intervention groups significantly improved COT (Ex = 92%, ExO = 102%; P < .01) and PWT (Ex = 54%, ExO = 103%; P < .001). There was no change (P > .05) in either standard-of-care group. CONCLUSIONS: Individuals who are obese and nonobese with PAD made similar improvements after a 6-month, center-based walking program. However, patients who are obese with PAD and do not exercise may be susceptible to greater declines in mobility. Exercise may be particularly important in patients who are obese with PAD to avoid declines in mobility.
RCT Entities:
BACKGROUND AND PURPOSE: Both obesity and peripheral artery disease (PAD) limit function and may work additively to reduce mobility. The purpose of this study was to compare the effects of a 6-month, center-based walking program on mobility function between adults who are weight-stable obese and nonobese with PAD. METHODS: This is a secondary data analysis of 2 combined studies taken from previous work. Fifty-three adults with PAD and intermittent claudication participated in 6 months of treadmill training or standard of care. Patients were divided into 4 groups for analyses: exercise nonobese (Ex), exercise obese (ExO), standard-of-care nonobese (SC), and standard-of-care obese (SCO). Mobility was assessed by a standardized treadmill test to measure claudication onset time (COT) and peak walking time (PWT) as well as the distance walked during a 6-minute walk distance (6MWD) test. RESULTS: There was a significant (P < .001) interaction (intervention × obesity) effect on 6MWD, wherein both exercise groups improved (Ex = 7%, ExO = 16%; P < .02), the SC group did not change (0.9%; P > .05), and the SCO group tended to decline (-18%; P = .06). Both exercise intervention groups significantly improved COT (Ex = 92%, ExO = 102%; P < .01) and PWT (Ex = 54%, ExO = 103%; P < .001). There was no change (P > .05) in either standard-of-care group. CONCLUSIONS: Individuals who are obese and nonobese with PAD made similar improvements after a 6-month, center-based walking program. However, patients who are obese with PAD and do not exercise may be susceptible to greater declines in mobility. Exercise may be particularly important in patients who are obese with PAD to avoid declines in mobility.
Authors: A W Gardner; L I Katzel; J D Sorkin; D D Bradham; M C Hochberg; W R Flinn; A P Goldberg Journal: J Am Geriatr Soc Date: 2001-06 Impact factor: 5.562
Authors: Katherine A Mockford; Fayyaz A K Mazari; Alastair R Jordan; Natalie Vanicek; Ian C Chetter; Patrick A Coughlin Journal: Ann Vasc Surg Date: 2011-02 Impact factor: 1.466
Authors: Mary M McDermott; Kiang Liu; Luigi Ferrucci; Lu Tian; Jack M Guralnik; Yihua Liao; Michael H Criqui Journal: J Am Coll Cardiol Date: 2011-02-22 Impact factor: 24.094
Authors: M M McDermott; P Greenland; K Liu; J M Guralnik; M H Criqui; N C Dolan; C Chan; L Celic; W H Pearce; J R Schneider; L Sharma; E Clark; D Gibson; G J Martin Journal: JAMA Date: 2001-10-03 Impact factor: 56.272
Authors: A W Gardner; L I Katzel; J D Sorkin; L A Killewich; A Ryan; W R Flinn; A P Goldberg Journal: J Gerontol A Biol Sci Med Sci Date: 2000-10 Impact factor: 6.053
Authors: Raphael Mendes Ritti Dias; Cláudia Lúcia de Moraes Forjaz; Gabriel Grizzo Cucato; Luis Augusto Riani Costa; Lucas Caseri Câmara; Nelson Wolosker; Maria de Fátima Nunes Marucci Journal: Gerontology Date: 2008-09-11 Impact factor: 5.140
Authors: Stephen P Messier; Richard F Loeser; Gary D Miller; Timothy M Morgan; W Jack Rejeski; Mary Ann Sevick; Walter H Ettinger; Marco Pahor; Jeff D Williamson Journal: Arthritis Rheum Date: 2004-05
Authors: David G Embrey; Gad Alon; Brenna A Brandsma; Felix Vladimir; Angela Silva; Bethann M Pflugeisen; Paul J Amoroso Journal: Int J Cardiol Date: 2017-06-02 Impact factor: 4.164